Table III.

Serum parameters in effect of MARS treatments. Albumin and INR results are also influenced by exogenous supplement. Decrease in the level of cholinesterase, and the slight increase of ammonia level shows that MARS therapy could not entirely keep up with the progression of liver failure

Parameter	Unit	Before MARS	After MARS	Percent change	p Value
Carbamide	mmol/L	20.5 ± 12.0	13.7 ± 6.7	−0.3318	0.0488
Creatinine	μmol/L	213.6 ± 85.7	151.8 ± 51.7	−0.2891	0.0155
Bilirubin, total	μmol/L	411.4 ± 250.0	325.6 ± 156.0	−0.2085	0.0126
Bilirubin, conj.	mmol/L	318.8 ± 237.0	224.0 ± 147.5	−0.2972	0.0077
ALP	U/L	272.7 ± 115.8	234.6 ± 89.5	−0.1397	0.0607
SGOT	U/L	535.5 ± 746.7	375.9 ± 379.7	−0.2981	0.0856
SGPT	U/L	420.2 ± 450.9	368.4 ± 353.7	−0.1232	0.0152
GGT	U/L	108.9 ± 65.0	92.9 ± 54.5	−0.147	0.0210
LDH	U/L	702.0 ± 382.3	462.9 ± 272.4	−0.3406	0.1122
Lactate	mmol/L	7.2 ± 1.5	4.7 ± 1.8	−0.3431	N/A
Cholinesterase	U/L	5897.9 ± 1514.2	5198.5 ± 1348.2	−0.1186	0.0876
Ammonia	μmol/L	73.6 ± 56.4	75.0 ± 49.8	0.019	0.2995
Albumin	g/L	37.3 ± 5.67	43.6 ± 10.33	0.1693	0.0247
INR		1.8 ± 0.6	1.9 ± 0.5	0.0875	0.2443
MELD		32.1 ± 4.5	28.4 ± 4.2	−0.1144	0.028